2025 Europe Biobanking Market Revenue Opportunities Report
Description
The 2025 Europe Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European biobanking market are Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich Inc.), Qiagen NV, and BioLife Solutions Inc. Thermo Fisher Scientific leads with extensive biobanking equipment and services, significantly influencing research through advanced sample management systems. Merck KGaA, via its Sigma-Aldrich brand, offers consumables and reagents vital for biobank operations. Qiagen NV specializes in sample collection and molecular diagnostics, supporting both research and clinical biobanks. BioLife Solutions provides storage and logistics solutions essential for sample preservation and transport in European biobanks.
These companies contribute to Europe's dominance in the global biobanking market, which generated over USD 29 billion in revenue in 2023 and is growing at a CAGR near 8.9%. Their participation aligns with Europe’s strong regulatory frameworks, advanced healthcare infrastructure, and collaborative research initiatives such as BBMRI-ERIC. They also benefit from significant R&D investments and robust government funding supporting biobank expansion, sample quality management, and data integration technologies. This ecosystem facilitates precision medicine and disease research across Europe, reinforcing the market leadership of these key players.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European biobanking market are Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich Inc.), Qiagen NV, and BioLife Solutions Inc. Thermo Fisher Scientific leads with extensive biobanking equipment and services, significantly influencing research through advanced sample management systems. Merck KGaA, via its Sigma-Aldrich brand, offers consumables and reagents vital for biobank operations. Qiagen NV specializes in sample collection and molecular diagnostics, supporting both research and clinical biobanks. BioLife Solutions provides storage and logistics solutions essential for sample preservation and transport in European biobanks.
These companies contribute to Europe's dominance in the global biobanking market, which generated over USD 29 billion in revenue in 2023 and is growing at a CAGR near 8.9%. Their participation aligns with Europe’s strong regulatory frameworks, advanced healthcare infrastructure, and collaborative research initiatives such as BBMRI-ERIC. They also benefit from significant R&D investments and robust government funding supporting biobank expansion, sample quality management, and data integration technologies. This ecosystem facilitates precision medicine and disease research across Europe, reinforcing the market leadership of these key players.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
